Literature DB >> 3718231

Acute toxicity of pyridostigmine in rats: histological findings.

J O Gebbers, M Lötscher, W Kobel, R Portmann, J A Laissue.   

Abstract

To assess the morphological changes due to pyridostigmine (Pyr), sublethal doses of Pyr (20 and 40 mg/kg body weight) were given to adult rats through a gastric tube. Within 24 h, acute focal necroses, leukocytic infiltrates and marked changes in the motor endplates appeared in the skeletal muscle. The changes were more evident in the diaphragm than in the quadriceps muscle. The acetylcholinesterase activity in the whole blood and in the erythrocytes was reduced to considerably less than one-half of the normal value. The histological changes induced by Pyr have not been reported to date, but are similar to those observed in experimental poisoning with other anticholinesterase agents such as carbamates and organophosphates.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3718231     DOI: 10.1007/bf00297119

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  33 in total

1.  Initial ultrastructural abnormalities at the motor end plate produced by a cholinesterase inhibitor.

Authors:  M B Laskowski; W H Olson; W D Dettbarn
Journal:  Exp Neurol       Date:  1977-10       Impact factor: 5.330

2.  An experimental myopathy secondary to excessive acetylcholine release.

Authors:  G M Fenichel; W D Dettbarn; T M Newman
Journal:  Neurology       Date:  1974-01       Impact factor: 9.910

3.  Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine-DTNB procedure.

Authors:  G Voss; K Sachsse
Journal:  Toxicol Appl Pharmacol       Date:  1970-05       Impact factor: 4.219

4.  Properties of soleus muscle Z-lines and induced Z-line analogs revealed by dissection with Ca2+-activated neutral protease.

Authors:  M Yamaguchi; R M Robson; M H Stromer; N R Cholvin; M Izumimoto
Journal:  Anat Rec       Date:  1983-08

5.  The use of therapeutic mixtures in the treatment of cholinesterase inhibition.

Authors:  D Gall
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr

6.  The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies.

Authors:  A Akaike; S R Ikeda; N Brookes; G J Pascuzzo; D L Rickett; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1984-01       Impact factor: 4.436

7.  [Pharmacological effects of Roche mestinon: 1-methyl-3-(dimethylcarbamyloxypyridinium bromide); pyridostigmine bromide].

Authors:  K FROMHERZ; B PELLMONT
Journal:  Schweiz Med Wochenschr       Date:  1953-12-05

8.  Endplates after esterase inactivation in vivo: correlation between esterase concentration, functional response and fine structure.

Authors:  M M Salpeter; H Kasprzak; H Feng; H Fertuck
Journal:  J Neurocytol       Date:  1979-02

9.  Toxicity of anticholinesterases: interactions of pyridostigmine and physostigmine with soman.

Authors:  L W Harris; W J Lennox; B G Talbot; D R Anderson; D R Swanson
Journal:  Drug Chem Toxicol       Date:  1984       Impact factor: 3.356

10.  Agonist-induced myopathy at the neuromuscular junction is mediated by calcium.

Authors:  J P Leonard; M M Salpeter
Journal:  J Cell Biol       Date:  1979-09       Impact factor: 10.539

View more
  2 in total

1.  Role of acetylcholine in pyridostigmine-induced myocardial injury: possible involvement of parasympathetic nervous system in the genesis of cardiomyopathy.

Authors:  T Kato; S Sugiyama; Y Hanaki; A Fukushima; N Akiyama; T Ito; T Ozawa
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

2.  Effects of experimental sarin intoxication on the morphology of the mouse diaphragm: a light and electron microscopical study.

Authors:  J N Hughes; R Knight; R F Brown; T C Marrs
Journal:  Int J Exp Pathol       Date:  1991-04       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.